Skip to main content

Table 3 Literature of single fraction SRS to the resection cavity

From: Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases

Authors & year

No. cavities

Treatment modality

Median dose (Gy)

Crude LF (%)

DF (%)

Salvage WBRT (%)

LMC (%)

MS (mos)

Iwai et al., 2008 [19]

21

GK

17

24

48

NR

24

20

Do et al., 2009 [26]

33

LINAC

15

12

63

47

NR

12

Jagannathan et al., 2009 [27]

47

GK

19

7

87

28

NR

11

Karlovits et al., 2009 [28]

52

LINAC

15

8

55

31

NR

15

Limbrick et al., 2009 [29]

16

GK

20

27

60

40

NR

20

Hwang et al., 2010 [30]

25

GK

15–20a

0

33

NR

NR

15

Kalani et al., 2010 [31]

68

GK

15

21

NR

NR

NR

13.2

Jensen et al., 2011 [15]

112

GK

17

13

54

37

7.5

10.9

Rwigema et al., 2011 [20]

77

CK

18

26

47

26

NR

14.5

Kelly et al., 2012 [32]

18

LINAC

18

11

35

24

NR

N/A

Ogiwara et al., 2012 [33]

56

GK

16

9

38

14

NR

21

Prabhu et al., 2012 [22]b

64

LINAC

18

17

NR

NR

NR

13

Robbins et al., 2012 [16]

85

LINAC

16

19

55

35

8.2

12

Broemme et al., 2013 [23]b

44

LINAC

17c, 24d

9

66

36

NR

15.9

Hartford et al., 2013 [35]

49

LINAC

10

16

63

45

NR

NR

Luther et al., 2013 [17]

120

GK

16

14

40

NR

NR

NR

Brennan et al., 2014 [34]

40

LINAC

18

30

47

NR

NR

14.7

Ojerholm et al., 2014 [18]

96

GK

16

18

54

33

14

22.3

  1. No. number, GK Gamma Knife, LINAC linear accelerator, CK Cyberknife, LF local failure, DF distant failure, MS median survival, LMC leptomeningeal carcinomatosis, mos months, NR not reported, N/A not applicable
  2. aReported range
  3. bMajority single fraction SRS
  4. cMedian single fraction dose
  5. dMedian multi fraction dose